Dexamethasone-induced FKBP51 expression in peripheral blood mononuclear cells could play a role in predicting the response of asthmatics to treatment with corticosteroids

Journal of Clinical Immunology

Volumn 31, Issue 1, 2011, Pages 122-127

  Chun, Eunyoung ^a   Lee, Hyun Seung ^a   Bang, Bo Ram ^a   Kim, Tae Wan ^a   Lee, So Hee ^a   Kim, Ju Han ^a   Cho, Sang Heon ^a   Min, Kyung Up ^a   Kim, You Young ^a   Park, Heung Woo ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Asthma; FKBP51; glucocorticoids; peripheral blood mononuclear cells

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; FK 506 BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; PREDNISOLONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; FEMALE; FKBP51 GENE; FORCED EXPIRATORY VOLUME; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; LUNG FUNCTION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANIMALS; ASTHMA; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; TACROLIMUS BINDING PROTEINS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953854400     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9463-9     Document Type: Article

References (27)

1. National Asthma Education and Prevention Program (2007) Guidelines for the diagnosis and management of asthma: Expert Panel Report 2. Publication #08-4051. Bethesda (MD): National Institutes of Health/National Heart, Lung, and Blood Institute
2. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143-78.
3. Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med. 1999;130:487-95.
4. Kerrebijn KF, van Essen-Zandvliet EE, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987;79:653-9. (Pubitemid 17056922)
5. Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109:410-8. (Pubitemid 34234189)
6. Martin RJ, Szefler SJ, King TS, et al. The predicting response to inhaled corticosteroid efficacy (PRICE) trial. J Allergy Clin Immunol. 2007;119:73-80. (Pubitemid 46037824)
7. Smith AD, Cowan JO, Brassett KP, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med. 2005;172:453-9. (Pubitemid 41117391)
8. Boulet LP, Becker A, Be'rube' D, et al. Canadian asthma consensus report. Can Med Assoc J. 1999;161(Suppl11):S1-62.
9. Ungar WJ, Champman KR, Santos MT. Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med. 2002;165:190-4. (Pubitemid 34084456)
10. Vermeer H, Hendriks-Stegeman BI, Verrijn Stuart AA, et al. A comparison of in vitro bioassays to determine cellular glucocorticoid sensitivity. Eur J Endocrinol. 2004;150:41-7. (Pubitemid 38159739)
11. Vermeer H, Hendriks-Stegeman BI, van der Burg B, et al. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab. 2003;88:277-84. (Pubitemid 36115178)
12. Vermeer H, Hendriks-Stegeman BI, van Suylekom D, et al. An in vitro bioassay to determine individual sensitivity to glucocorticoids: induction of FKBP51 mRNA in peripheral blood mononuclear cells. Mol Cell Endocrinol. 2004;218:49-55. (Pubitemid 38578427)
13. Davies TH, Ning YM, Sánchez ER. A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem. 2002;277:4597-600. (Pubitemid 34968486)
14. Wochnik GM, Ruegg J, Abel GA, et al. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem. 2005;280:4609-16. (Pubitemid 40288629)
15. Denny WB, Valentine DL, Reynolds PD, et al. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology. 2000;141:4107-13.
16. Denny WB, Prapapanich V, Smith DF, et al. Structure-function analysis of squirrel monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity. Endocrinology. 2005;146:3194-01.
17. Woodruff PG, Boushey HA, Dolganov GM, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA. 2007;104:15858-63. (Pubitemid 350035389)
18. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2006;117:522-43. (Pubitemid 43340215)
19. Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bull. 2000;56:1054-70. (Pubitemid 32417168)
20. Pavord ID, Brightling CE, Woltmann G, et al. Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999;353:2213-4. (Pubitemid 29295261)
21. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;360:973-84.
22. Adcock IM, Barnes PJ. Molecular mechanisms of corticosteroid resistance. Chest. 2008;134:394-401.
23. McKeen HD, McAlpine K, Valentine A, et al. A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling. Endocrinology. 2008;149:5724-34.
24. Reynolds PD, Ruan Y, Smith DF, et al. Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J Clin Endocrinol Metab. 1999;84:663-9. (Pubitemid 29075703)
25. Baptist AP, Reddy RC. Inhaled corticosteroids for asthma: are they all the same? J Clin Pharm Ther. 2009;34:1-12.
26. Motsinger AA, Ritchie MD, Reif DM. Novel methods for detecting epistasis in pharmacogenomics studies. Pharmacogenomics. 2007;8:1229-41. (Pubitemid 47591323)
27. Wilke RA, Reif DM, Moore JH. Combinatorial pharmacogenetics. Nat Rev Drug Discov. 2005;4:911-8. (Pubitemid 41637693)